Valiant Organics Board Approves Q1 FY27 Results & Reappoints MD
Valiant Organics reported Q1 FY27 results with consolidated profit after tax at ₹2,926.33 lakhs. The Board re-appointed Shri Sathiababu K. Kallada as Managing Director for three years from May 24, 2027. The registered office will be shifted to Tarapur, Palghar, subject to shareholder approval.
The re-appointment of the Managing Director and the approval of financial results are material events for the company. The relocation of the registered office is a significant operational change. These factors collectively have a medium-term impact on the company's governance and operations.
The positive sentiment is driven by the approval of financial results and the re-appointment of the Managing Director, indicating stability and continued leadership. The relocation of the registered office, while a procedural change, is also approved by the board.
Valiant Organics Limited announced the outcome of its Board Meeting held on August 12, 2026. The Board approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.
The company reported its financial results for the quarter ended June 30, 2026. For standalone operations, total income was ₹23,418.05 lakhs, with a profit after tax of ₹2,182.27 lakhs. Consolidated total income stood at ₹23,481.61 lakhs, and profit after tax was ₹2,926.33 lakhs.
Furthermore, the Board approved the re-appointment of Shri Sathiababu K. Kallada as the Managing Director for a term of three years, effective from May 24, 2027, to May 23, 2030. This re-appointment is subject to shareholder approval at the upcoming Annual General Meeting. Shri Sathiababu K. Kallada has over 38 years of experience in the chemical industry.
The Board also approved the shifting of the Company's Registered Office from Mulund, Mumbai, to Plot No. M-7, MIDC, Tarapur, Boisar, Palghar, Maharashtra. This relocation is also subject to shareholder approval at the ensuing Annual General Meeting. The Corporate Office has been relocated to 701-A, Tower-B, Embassy 247 Park, Gandhi Nagar, Vikhroli (West), Mumbai – 400083.
The Board Meeting commenced at 12:35 PM IST and concluded at 03:50 PM IST.
What to do with a filing like this
Valiant Organics Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Valiant Organics Limited. Read the original for the full detail.